Navigation Links
Inhalable gene therapy may help pulmonary arterial hypertension patients
Date:7/30/2013

ife sustaining therapy."

When SERCA2a is down-regulated, calcium stays longer in the cells than it should, and it induces pathways that lead to overgrowth of new and enlarged cells. According to researchers, the delivery of the SERCA2a gene produces SERCA2a enzymes, which helps both heart and lung cells restore their proper use of calcium.

"We are now on a path toward PAH patient clinical trials in the near future," says Dr. Hajjar, who developed the gene therapy approach. Studies in large animal models are now underway. SERCA2a gene therapy has already been approved by the National Institutes of Health for human study.

A Simple Inhalation Corrects Deadly Dysfunction

PAH most commonly results from heart failure in the left side of the heart or from a pulmonary embolism, when clots in the legs travel to the lungs and cause blockages. When the lung is damaged from these conditions, the tissue starts to quickly produce new and enlarged cells, which narrows pulmonary arteries. This increases the pressure inside them. The high pressure in these arteries resists the heart's effort to pump through them and the blood flow between the heart and lungs is reduced. The right side of the heart then must overcome the resistance and work harder to push the blood through the pulmonary arteries into the lungs. Over time, the right ventricle becomes thickened and enlarged and heart failure develops.

The gene therapy that Dr. Hajjar developed uses a modified adeno-associated viral-vector that is derived from a parvovirus. It works by introducing a healthy SERCA2a gene into cells, but this gene does not incorporate into a patient's chromosome, according to the study's lead author, Lahouaria Hadri, PhD, an Instructor of Medicine in Cardiology at Icahn School of Medicine at Mount Sinai.

"The clinical trials in congestive heart failure have shown already that the gene therapy is very safe," says Dr. Hadri. Between 40-50 pe
'/>"/>

Contact: Lauren Woods
lauren.woods@mountsinai.org
212-241-2836
The Mount Sinai Hospital / Mount Sinai School of Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. KRAS gene mutation and amplification status affects sensitivity to antifolate therapy
2. Antibody therapy prevents gastrointestinal damage following radiation exposure in mice
3. Chemotherapy proves life-saving for some leukemia patients who fail induction therapy
4. Immunotherapy for elderly cancer patients finds new promise in drug combination
5. Therapy exploits addiction of leukemia cells
6. Intensity Modulated Radiation Therapy optimal for localized prostate cancer
7. Adding drug to standard chemotherapy provides no survival benefit for older lung cancer patients
8. Study Casts Doubt on Value of Pricey Prostate Cancer Therapy
9. 19th century therapy for Parkinsons disease may help patients today
10. New Psoriasis Drugs Not Much Better Than Standard Therapy, Study Finds
11. Xenotransplantation as a therapy for type 1 diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2015)... Boston, MA (PRWEB) May 03, 2015 ... received clearance from the FDA to produce and market ... This device can be used in outpatient settings and ... , The alternate posterior approach has been extensively researched ... a 510k approval to use this approach in conjunction ...
(Date:5/2/2015)... May 02, 2015 Vancouver fencing company, QS ... provide valuable advice to prospective clients related to their questions ... to install railings around their decks and patios. While that ... that pop up once the person rolls up their sleeve ... installing a railing in finding a gate that matches it. ...
(Date:5/2/2015)... Peachtree Audio ” was featured on NewsWatch as part ... and coolest technology products available to consumers. Scott Steinberg, ... the review and shared with viewers how this is ... important part of people’s lives – and as such, ... Peachtree Audio does just that with high-end audio equipment ...
(Date:5/2/2015)... May 02, 2015 With the success that ... is proud to welcome Neida Miranda and Alex Shields to ... Consulting has over 41 years of combined experience working with ... in the dental field for 8 years. She was ... Waco, Texas. Customer service, positive attitude and showing the importance ...
(Date:5/1/2015)... Freeport, ME (PRWEB) May 01, 2015 ... store in Freeport, Maine, reports on a new study ... pain, stiffness, joint swelling and improved physical function as ... people with severe osteoarthritis of the knee. , The ... “ Natural Insights for Well Being® ,” which Royal ...
Breaking Medicine News(10 mins):Health News:Professional Staff at QS Fencing Company Now Provides Advice on Railings and Gates 2Health News:Affordable High-End Audio Equipment was Featured on NewsWatch Television 2Health News:Veatch Dental Consulting Services Welcomes New Team Members 2Health News:New Study Finds Nutrients Ease Arthritis Pain, Retailer Reports 2
... this week by the U.S. Supreme Court will protect the rights of ... LLP . “The Supreme Court’s ruling this week is an important victory ... attorney Robert Kientz. , ... Austin, TX (Vocus) March 6, 2009 -- ...
... but some people don,t realize how precious it really is. 24k gold ... formulas on the market. , ... New York (PRWEB) March 6, 2009 -- While watching ... Gold. It,s common to hear that it has kept a rather high ...
... Diagnosing and treating obstructive sleep apnea may soon ... new research showing that a simplified program using ... positive airway pressure (CPAP) machines to titrate CPAP ... which relies on specialist physicians and sleep studies. ...
... Medical Association (NMA) congratulates the President and his staff ... in today,s forum. The NMA is committed to ... advocacy community, and other stakeholders, to ensure that the ... the President can sign before the Congress adjourns for ...
... of Hispanic health advocates is committed to achieving meaningful ... have work to do to cover the uninsured, improve ... someone has access it is to the type of ... L. Delgado, President and CEO of the National Alliance ...
... Stockholders to Vote the GOLD CardCINCINNATI, March 5 ... announces that RiskMetrics Group,s ISS Governance Services has ... Company,s current Board of Directors and reject all ... and election of replacement Directors, in the Joffe ...
Cached Medicine News:Health News:Supreme Court Ruling is a Victory for Consumers Injured by Dangerous Drugs, Says Hissey Kientz, LLP 2Health News:Supreme Court Ruling is a Victory for Consumers Injured by Dangerous Drugs, Says Hissey Kientz, LLP 3Health News:Gold Not Only Valuable, It's a Healthy Skin Care Ingredient 2Health News:Less costly, more accessible and as effective: Simplified treatment for sleep apnea 2Health News:Less costly, more accessible and as effective: Simplified treatment for sleep apnea 3Health News:Alliance President and CEO Dr. Jane L. Delgado Joins President Obama at White House to Launch Health Reform Agenda 2Health News:Leading Proxy Advisory Firm RiskMetrics Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Proposals by Dissident Joffe Group 2Health News:Leading Proxy Advisory Firm RiskMetrics Recommends Shareholders Support LCA-Vision Board of Directors and Reject All Proposals by Dissident Joffe Group 3
(Date:4/30/2015)... 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX: PVTTF) ... focus on Omega-3 therapies for cardiovascular disease (CVD) ... financial results for the fiscal year ended December ... in Canadian dollars unless otherwise stated. ... the right strategic partners and additional capitalization in ...
(Date:4/30/2015)... VIEW, Calif. , April 30, 2015  IRIDEX ... will release its first quarter 2015 financial results after ...   In conjunction with the release, the Company will ... 5:00 p.m. Eastern Time on Thursday, ... the quarter and other business developments. Interested ...
(Date:4/30/2015)... NASHVILLE, Tenn. , April 30, 2015  Cumberland ... it will release first quarter 2015 financial results after ... conference call and live Internet webcast will be held ... Time to discuss the results. To participate ... or 253-237-1032 (for international callers).  A rebroadcast of the ...
Breaking Medicine Technology:Pivotal Therapeutics Announces 2014 Financial Results 2Pivotal Therapeutics Announces 2014 Financial Results 3Pivotal Therapeutics Announces 2014 Financial Results 4Pivotal Therapeutics Announces 2014 Financial Results 5Pivotal Therapeutics Announces 2014 Financial Results 6IRIDEX Announces First Quarter 2015 Conference Call and Release Date 2Cumberland Pharmaceuticals To Announce First Quarter 2015 Financial Results 2
... Pharmasset, Inc. (Nasdaq: VRUS ) has received ... (FDA) for PSI-938 for the treatment of chronic hepatitis C ... polymerase inhibitor of HCV. In March 2011, ... has potent antiviral activity and is generally safe and well ...
... 24, 2011 MedVantx, Inc., the company that created first ... today announced that Inc. Magazine has rated the company as ...  For the third year in a row, MedVantx has made ... Health Industry and thirteenth overall. The Inc. 500/5000 ...
Cached Medicine Technology:PSI-938 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 2PSI-938 Receives Fast Track Designation from the FDA for the Treatment of Chronic Hepatitis C Infection 3MedVantx Honored by Inc. 500/5000 Three Years in a Row 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: